Product image of Menisy (Betahistine Dihydrochloride) supplied by GNH India

Menisy

Active Ingredient:
Betahistine Dihydrochloride
Origin:
EU

Menisy (Betahistine Dihydrochloride)

Betahistine Dihydrochloride, the active ingredient in Menisy, is a histamine analog (H1 agonist / H3 antagonist) presented as an oral tablet for oral use. It is employed to manage vestibular disorders such as Meniere’s disease, vertigo and other balance disturbances in adults.

GNH India supplies Menisy as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Stada Arzneimittel Ag

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Betahistine Dihydrochloride is used in the management of inner‑ear disorders that affect balance and hearing.

  • Meniere's disease: helps reduce the frequency and severity of vertigo attacks and may improve hearing stability.
  • Vertigo: alleviates episodes of dizziness associated with vestibular dysfunction.
  • Balance disorders: supports microcirculation in the inner ear to lessen imbalance symptoms.

How It Works

  • Betahistine Dihydrochloride acts as a histamine H1 receptor agonist and an H3 receptor antagonist. By stimulating H1 receptors, it promotes vasodilation and increases histamine turnover in the inner ear, enhancing microvascular blood flow. Antagonism of H3 receptors prevents feedback inhibition of histamine release, further supporting vascular perfusion and reducing vestibular hyperactivity.

Side Effects

Betahistine Dihydrochloride is generally well tolerated, but some patients may experience adverse reactions.

Common Side Effects

  • Headache: mild to moderate intensity.
  • Nausea: occasional gastrointestinal upset.
  • Gastric discomfort: mild abdominal pain or dyspepsia.
  • Dizziness: transient light‑headedness.
  • Skin flushing: temporary reddening of the face or neck.

Serious or Rare Side Effects

  • Rash or urticaria: signs of possible allergic reaction.
  • Hypotension: marked drop in blood pressure causing faintness.
  • Palpitations: irregular heartbeats.
  • Severe gastrointestinal bleeding: rare but requires immediate attention.

Precautions & Warnings

Before initiating therapy, consider the following safety measures.

  • Pregnancy: consult a healthcare professional; safety data are limited.
  • Breastfeeding: discuss potential risks with a physician.
  • Renal impairment: dose adjustment may be needed in severe cases.
  • Concomitant antihistamines: may blunt therapeutic effect.
  • Elderly patients: monitor for increased sensitivity to side effects.
  • Store at ambient temperature: keep below 25 °C, in the original packaging, protected from moisture and direct sunlight.

Avoid Interactions

Betahistine Dihydrochloride may interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid)

  • Strong antihistamines (e.g., diphenhydramine): may reduce therapeutic benefit.
  • Monoamine oxidase inhibitors (MAOIs): potential for exaggerated vasodilatory response.

Moderate Interactions (Monitor Closely)

  • Antihypertensive agents: additive blood pressure‑lowering effect.
  • Diuretics: may increase risk of electrolyte imbalance.
  • CYP450 substrates: monitor if co‑administered with drugs metabolized by the same pathway, although betahistine has minimal CYP involvement.

Frequently Asked Questions

Menisy contains betahistine dihydrochloride and is indicated for the management of vestibular disorders such as Meniere’s disease, episodic vertigo and other balance‑related conditions. It helps improve inner‑ear microcirculation, which can reduce the frequency and intensity of dizziness episodes.

Betahistine acts as a histamine H1 receptor agonist and an H3 receptor antagonist. Stimulation of H1 receptors causes vasodilation and increased blood flow in the inner ear, while H3 antagonism prevents feedback inhibition of histamine release, together enhancing microvascular circulation and stabilising vestibular function.

The appropriate dose of Menisy is determined by the prescribing healthcare professional based on the individual’s condition, severity of symptoms and overall health status. Patients should follow the prescriber’s instructions and not adjust the dose without medical guidance.

Safety data for betahistine during pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare provider before starting Menisy.

To request Menisy, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Menisy (betahistine) differs from antihistamines such as dimenhydrinate, which primarily block H1 receptors and can cause sedation. Betahistine’s dual H1 agonist/H3 antagonist action promotes inner‑ear blood flow rather than suppressing vestibular activity, offering a distinct therapeutic approach for conditions like Meniere’s disease.

Menisy should be stored at ambient temperature, preferably below 25 °C. Keep the tablets in their original packaging, protect them from moisture and direct sunlight, and ensure they are out of reach of children.

Menisy is taken orally, usually with or without food, as directed by a healthcare professional. Swallow the tablet whole with a glass of water and do not crush or chew it unless specifically instructed.

Serious but rare adverse reactions to Menisy may include severe allergic responses such as rash, urticaria, or anaphylaxis, marked hypotension, and significant gastrointestinal bleeding. Patients experiencing any of these symptoms should seek immediate medical attention.

Menisy is contraindicated in individuals with known hypersensitivity to betahistine or any of its excipients. Caution is advised for patients with severe renal impairment, uncontrolled hypertension, or those taking strong antihistamines that may diminish its effectiveness.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Betahistine Dihydrochloride

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT